Literature DB >> 21390057

Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus.

E Laugesen1, N B Rossen, P L Poulsen, K W Hansen, E Ebbehøj, S T Knudsen.   

Abstract

Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease (CVD). We examined the predictive ability of 24-hour ambulatory pulse pressure (24-h PP), ambulatory arterial stiffness index (AASI) and diurnal blood pressure (BP) parameters for fatal and non-fatal CVD in patients with type 2 diabetes mellitus. A total of 108 patients with type 2 diabetes mellitus (mean duration 6.6 years) were followed for 9.5 (0.5-14.5) years. At baseline, all patients underwent ambulatory BP monitoring. During follow-up, 45 patients had cardiovascular (CV) events (35 non-fatal and 10 fatal). In bivariate analysis, events during follow-up were predicted by 24-h PP (P<0.01), AASI, 24-h systolic BP and systolic and diastolic night-day BP ratio (P<0.05 for all). In Cox regression analysis adjusted for established risk markers, only 24-h PP and systolic night-day BP ratio predicted CV events, P<0.05 for both. A significant interaction between the two parameters was found, P<0.05; thus, the higher the systolic night-day ratio, the greater the increase in hazard ratio (HR) per mmHg increase in 24-h PP and vice versa. A combined 10 mmHg increase in 24-h PP and 10%-point increase in systolic night-day ratio from the 25th percentile increased the adjusted HR (95% confidence interval) for CV events with 1.29 (0.53; 3.12), whereas a similar increase from the 75th percentile increased the HR with 4.2 (1.54; 11,51). Our study showed that 24-h PP and systolic night-day ratio interact as predictors of CV events in type 2 diabetes patients, and should be considered in conjunction when evaluating the risk of CVD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390057     DOI: 10.1038/jhh.2011.9

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension.

Authors:  C S Oxlund; C Cangemi; J E Henriksen; I A Jacobsen; J Gram; K Schousboe; L Tarnow; W S Argraves; L M Rasmussen
Journal:  J Hum Hypertens       Date:  2014-04-17       Impact factor: 3.012

2.  Comparison of ambulatory blood pressure and clinic blood pressure in relation to cardiovascular diseases in diabetic patients.

Authors:  Jian Shen; Zhi-Ming Li; Li-Zhen He; Ren-Sheng Deng; Jing-Guang Liu; Yuan-Sheng Shen
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

3.  Relationship and associated mechanisms between ambulatory blood pressure and clinic blood pressure with prevalent cardiovascular disease in diabetic hypertensive patients.

Authors:  Zirui Hao; Guiping Li; Yue Sun; Yan Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Morning blood pressure surge and target organ damage in newly diagnosed type 2 diabetic patients: a cross sectional study.

Authors:  Johanne M Lyhne; Esben Laugesen; Pernille Høyem; Simon Cichosz; Jens S Christiansen; Søren T Knudsen; Klavs W Hansen; Troels K Hansen; Per L Poulsen
Journal:  BMC Endocr Disord       Date:  2015-12-03       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.